|
KOREA LIFE SCIENCE
|
M.TECH STS CO., LTD.
|
Protective & Infection-Prevention Products for Biohealth Worksites
|
G42
|
|
KOREA LIFE SCIENCE
|
MBD (Medical & Bio Decision)
|
ASFA Spotter Mini (Automated 3D Cell & ECM Dispenser)
|
C42
|
|
KOREA LAB Autumn
|
MDK
|
NIR & RAMAN Analyzer, Water Analyzer, Peristaltic & Syringe Pump, Smart Stirrer, Gas Volume and Flow Meter, Antimicrobial Keyboard & Mouse
|
H21
|
|
PARTNERING
|
MediciBIO
|
MediciBio’s next-generation LNP platform consists of systemic, local, and organ-targeted delivery systems. Systemic LNPs provide excellent gene delivery with repeat dosing, local LNPs reduce unnecessary systemic exposure to enhance safety, and organ-targeted LNPs use proprietary lipids for precise delivery to organs such as spleen and lungs. This differentiated technology is broadly applicable to next-generation genetic therapeutics, including mRNA treatments and vaccines. In RNA therapeutics, we are developing a mutation-selective ASO for Avellino corneal dystrophy, a rare disorder. This therapy selectively suppresses mutant TGFBI mRNA, demonstrating safety and efficacy, and its eye-drop formulation offers convenient administration with potential to become world’s first approved treatment
|
H60
|
|
PARTNERING
|
Medience Co
|
Poster 2 sheets, Products of Medience Co.
|
H60
|
|
NextRegenX
|
Medikan Co., Ltd.
|
Automated stem cell separation device (STEM-XE One), Integrated adipose tissue aspiration system (Lipokit Neo), Device that fragments adipose tissue to create Fat Gel (FillerGeller), Cell storage and preservation with automated cryogenic freezing (CryoHybrid), Convenient multi-filtration system to isolate high-purity exosomes (X-Trap), Remote-observable cell culture device (Storage Box P)
|
B41
|
|
NextRegenX
|
MEDVIA CO., LTD.
|
Regulatory Affairs and Clinical Strategy
|
C26
|
|
NextRegenX
|
MEPSGEN
|
(1) MEPS-TBC-WL, (2) MEPS-TBC-CH, (3) MEPS-ORD, (4) ProMEPS™, (5) NanoCalibur™ Lab
|
A22
|
|
PARTNERING
|
Micromediome
|
Microbiome-Based Adjuvant for Radiotherapy & Immuno-Oncology via TME Modulation
|
E41
|
|
PARTNERING
|
Mitos Therapeutics Inc.
|
Treatment of Sarcopenia
|
E41
|
KYUNGYON EXHIBITION CORP.